Be a Smart Investor
Wednesday, January 18, 2017
Gainers & Losers Of The Day: APRI, LIFE, JAZZ, ETRM, BIOC...
Lilly is all set to acquire CoLucid Pharma for $46.50 per share in cash or approximately $960 million.
from RTT - Biotech http://ift.tt/2jaBJWs
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment